Worth Watching Stocks : LookSmart (NASDAQ:LOOK), Conatus Pharmaceuticals (NASDAQ:CNAT), Castlight Health (NYSE:CSLT), InterDigital (NASDAQ:IDCC), Hampden Bancorp (NASDAQ:HBNK)

On August 14, 2014, LookSmart, Ltd. (NASDAQ:LOOK) announced that Lori House has resigned her position as the Company’s Principal Financial Officer and Principal Accounting Officer, effective August 11, 2014. She will continue to consult for the company and assist the company in preparing its financial statements and assist the accounting staff. Steven Wang, the current Vice President of Finance and Controller and a seasoned veteran … Continue reading Worth Watching Stocks : LookSmart (NASDAQ:LOOK), Conatus Pharmaceuticals (NASDAQ:CNAT), Castlight Health (NYSE:CSLT), InterDigital (NASDAQ:IDCC), Hampden Bancorp (NASDAQ:HBNK)

Jayne Crisman09/0209/02

Investors Are Watching : Time Warner Inc. (NYSE:TWX), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Allegheny Technologies Inc. (NYSE:ATI), ArQule Inc. (NASDAQ:ARQL), USMD Holdings, Inc. (NASDAQ:USMD)

Time Warner Inc. (NYSE:TWX) cut its ties to Time Inc., the once-great magazine publisher. The Tribune Company, keeping its television stations, has created a separately traded entity called Tribune Publishing for its newspapers. News Corp. now holds Rupert Murdoch’s newspapers, while 21st Century Fox has his entertainment properties. E. W. Scripps sent its papers packing. Time Warner Inc. (NYSE:TWX) belongs to Services sector. Its net … Continue reading Investors Are Watching : Time Warner Inc. (NYSE:TWX), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Allegheny Technologies Inc. (NYSE:ATI), ArQule Inc. (NASDAQ:ARQL), USMD Holdings, Inc. (NASDAQ:USMD)

John Bellich08/1308/13

Trader’s Recap : Emergent BioSolutions (NYSE:EBS), Conatus Pharmaceuticals (NASDAQ:CNAT), Cabot Microelectronics (NASDAQ:CCMP), MakeMyTrip (NASDAQ:MMYT), Vision-Sciences Inc. (NASDAQ:VSCI)

Emergent BioSolutions Inc. (NYSE:EBS) announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration (FDA) for Anthrax Immune Globulin Intravenous (Human) [AIGIV] as part of a development contract with the Biomedical Advanced Research and Development Authority (BARDA). AIGIV, which was acquired in the Cangene acquisition completed earlier this year, is being developed as an intravenous therapeutic treatment for inhalation … Continue reading Trader’s Recap : Emergent BioSolutions (NYSE:EBS), Conatus Pharmaceuticals (NASDAQ:CNAT), Cabot Microelectronics (NASDAQ:CCMP), MakeMyTrip (NASDAQ:MMYT), Vision-Sciences Inc. (NASDAQ:VSCI)

Chris Lewis08/1208/12

Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

A Palo Alto startup will focus an $18 million VC investment on developing a drug to stop unexplained recurrent miscarriages. Nora Therapeutics is capitalizing on work started by cofounder Darryl Carter at Johns Hopkins University that led to development of Nora’s lead drug, NT-100. Nora is led by CEO Jeff Tong, who had been vice president of corporate and product development at Infinity Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

Mark DeFrance04/2404/24